2009 Midyear Clinical Meeting
Click here to go to the previous page
From Research to Clinical Practice: Integrating Pharmacogenomics into Practice
Track:
Educational Sessions (CE)
Program Code: 271-L04
Date: Wednesday, December 9, 2009
Time: 4:00 PM to 5:00 PM EST
Location:
Palazzo L, Level 5
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Grace Kuo,
PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine,
University of California, San Diego
Dr. Kuo is Associate Professor of Clinical Pharmacy in the Skaggs School of Pharmacy and Pharmaceutical Sciences and Associate Adjunct Professor of Family and Preventive Medicine at the School of Medicine at UCSD. She serves as the Director of San Diego Pharmacist Resource and Research Network and the Director of the American College of Clinical Pharmacy Practice-Based Research Network.
Before pursuing a career in clinical pharmacy, Dr. Kuo received her undergraduate degree in psychobiology at UCLA. After receiving her pharmacy degrees from the Massachusetts College of Pharmacy and Oregon State University/Oregon Health Sciences University, she completed postdoctoral training at the W. G. Magnuson Clinical Center at the National Institutes of Health (NIH) in Bethesda, Maryland. Dr. Kuo also received a master of public health degree in health promotion and health education from the University of Texas.
Dr. Kuos research focuses on medication safety in the ambulatory care setting. She has received federal research funding from the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Centers for Disease Control and Prevention (CDC). Her research includes studying the effects of electronic medical records and patients health literacy on medication safety. She has a clinical scientist development award to evaluate the best practices for safe use of medications in the primary care setting. In addition, she is collaborating with other clinicians, educators, and researchers to start a shared curriculum related to pharmacogenomics education.
|
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Grace Kuo,
PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine,
University of California, San Diego
Dr. Kuo is Associate Professor of Clinical Pharmacy in the Skaggs School of Pharmacy and Pharmaceutical Sciences and Associate Adjunct Professor of Family and Preventive Medicine at the School of Medicine at UCSD. She serves as the Director of San Diego Pharmacist Resource and Research Network and the Director of the American College of Clinical Pharmacy Practice-Based Research Network.
Before pursuing a career in clinical pharmacy, Dr. Kuo received her undergraduate degree in psychobiology at UCLA. After receiving her pharmacy degrees from the Massachusetts College of Pharmacy and Oregon State University/Oregon Health Sciences University, she completed postdoctoral training at the W. G. Magnuson Clinical Center at the National Institutes of Health (NIH) in Bethesda, Maryland. Dr. Kuo also received a master of public health degree in health promotion and health education from the University of Texas.
Dr. Kuos research focuses on medication safety in the ambulatory care setting. She has received federal research funding from the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Centers for Disease Control and Prevention (CDC). Her research includes studying the effects of electronic medical records and patients health literacy on medication safety. She has a clinical scientist development award to evaluate the best practices for safe use of medications in the primary care setting. In addition, she is collaborating with other clinicians, educators, and researchers to start a shared curriculum related to pharmacogenomics education.
|
Mary Roederer,
PharmD, BCPS, Assistant Professor, Institute for Pharmacogenomics and Individualized Therapy,
University of North Carolina Eshelman School of Pharmacy
Mary W. Roederer graduated with her doctor of pharmacy degree from the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina. She completed a pharmacotherapy residency with the ECU Department of Family Medicine and Pitt County Memorial Hospital in Greenville, North Carolina. She has served as a clinical specialist in Family Medicine, clinical manager, and assistant director of pharmacy. Currently, Dr. Roederer works with the Institute of Pharmacogenomics and Individualized Therapy at UNC Chapel Hill. Her research interest lies in the global use of pharmacogenomics to prioritize formulary decisions for populations and to prioritize pharmacotherapy decisions for an individual.
|
Christine Walko,
PharmD, BCOP, Assistant Professor, Division of Pharmacotherapy and Experimental Therapeutics,
University of North Carolina Eshelman School of Pharmacy
Dr. Walko received her PharmD from Duquesne University in Pittsburgh, Pennsylvania, and worked as a research assistant at the University of Pittsburgh Cancer Insitute. She completed her pharmacy practice residency at the Medical College of Virginia and her hematology and oncology specialty residency at the University of North Carolina at Chapel Hill. She also completed her academic fellowship in Hematology and Oncology Pharmacotherapy at the University of North Carolina.
She joined the faculty in 2006 as a clinical assistant professor. She is the course coordinator of the Hematology and Oncology Pharmacotherapy Module taught in the fall of PY3 and the elective Advanced Hematology and Oncology course. She continunes to practice as a clinical pharmacist at the Lineberger Comprehensive Cancer Center clinic. Additionally, she collaborates with the LCCC investigators to pursue oncology-based research in translational pharmacology, Phase I/II trials, pharmacokinetics, and pharmacogenomics and is a member of the Institute of Pharmacogenomics and Individualized Therapy (IPIT).
|
Description
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists Taskforce on Science
ACPE Activity #204-000-09-271-L04P
1.0 Contact Hour / Knowledge-based
Educational Content: Level 2
Moderator: Grace M. Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla
4:00 p.m. – 4:05 p.m.
Announcements and Introductions
Grace M. Kuo
4:05 p.m. – 4:30 p.m.
Integrating Oncology Pharmacogenomics into Practice
Christine M. Walko, PharmD, BCOP, Assistant Professor, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill
4:30 p.m. – 4:55 p.m.
Integrating Infectious Diseases Pharmacogenomics into Practice
Mary W. Roederer, PharmD, BCPS, Assistant Professor, Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy; and Assistant Professor, Department of Family Medicine, University of North Carolina, Chapel Hill
4:55 p.m. – 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
- Discuss challenges faced by pharmacists when they try to incorporate available scientific evidence into practice.
- Discuss operational issues integrating pharmacogenomic testing into practice.
- Summarize key issues related to access to pharmacogenomic tests, patient education, cost, ethical issues, and feasibility.